Organigram Holdings Inc. (OGI) Earnings Call Analysis

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

18/25

Growth 5 Margin 3 Expansion 4 Platform 2 Financial 4

latest quarter score

Earnings Reports

18
OGI Q3 2026: Sanity Acquisition Drives 49% Revenue Growth and 37% Margin Expansion
August 11, 2026
17
Organigram (OGI) Q1 2026: 49% Revenue Growth, Margin Resilience Anchors Expansion Plans
June 15, 2026
18
Organigram (OGI) Q1 2026: 49% Revenue Surge Powered by Domestic Momentum, Margin Gains Hold Amid International Disruption
June 15, 2026
13
Organigram (OGI) Q2 2026: Sanity Group Adds €25M Quarterly Run Rate as International Shift Accelerates
May 13, 2026
19
Organigram (OGI) Q4 2025: International Sales Jump 171% as Margin Expansion Accelerates
December 16, 2025
17
Organigram (OGI) Q2 2025: International Sales Surge 177% as Global Expansion Accelerates
August 13, 2025
17
Organigram Global (OGI) Q2 2025: 74% Revenue Growth Driven by Motif Integration and International Expansion
May 12, 2025

Browse all companies